Copy
View this email in your browser

Dr Mal Ameratunga

Medical Oncologist, Alfred Health

“Beyond Driver Mutations: Using Molecular Profiling to inform Drug Repurposing in the Clinic”

Dr Ameratunga will discuss how novel computational approaches could be utilised to expand the array of therapies available to patients with poor prognosis and aggressive cancers.

Friday 29 April 2022
2pm to 3pm

Register for this seminar
Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research and clinical care programs.
Twitter
Website
LinkedIn
Copyright © 2022 MPCCC, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp